Connexin 43-modified bone marrow stromal cells reverse the imatinib resistance of K562 cells via Ca 2+ -dependent gap junction intercellular communication.
10.1097/CM9.0000000000002554
- Author:
Xiaoping LI
1
;
Yunshuo XIAO
2
;
Xiaoqi WANG
2
;
Ruihao HUANG
2
;
Rui WANG
2
;
Yi DENG
2
;
Jun RAO
2
;
Qiangguo GAO
3
;
Shijie YANG
2
;
Xi ZHANG
2
Author Information
1. Department of Hematology, 920th Hospital of Joint Logistic Support Force of People's Liberation, Kunming, Yunnan 650000, China.
2. Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing 400037, China.
3. Department of Cell Biology College of Basic Medicine, Army Medical University, Chongqing 400038, China.
- Publication Type:Journal Article
- MeSH:
Animals;
Humans;
Mice;
Apoptosis;
Bone Marrow Cells;
Cell Communication;
Connexin 43/genetics*;
Gap Junctions/metabolism*;
Imatinib Mesylate/therapeutic use*;
K562 Cells;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive/pathology*;
Mesenchymal Stem Cells/metabolism*;
Tumor Microenvironment;
Calcium/metabolism*
- From:
Chinese Medical Journal
2023;136(2):194-206
- CountryChina
- Language:English
-
Abstract:
BACKGROUND:Imatinib mesylate (IM) resistance is an emerging problem for chronic myeloid leukemia (CML). Previous studies found that connexin 43 (Cx43) deficiency in the hematopoietic microenvironment (HM) protects minimal residual disease (MRD), but the mechanism remains unknown.
METHODS:Immunohistochemistry assays were employed to compare the expression of Cx43 and hypoxia-inducible factor 1α (HIF-1α) in bone marrow (BM) biopsies of CML patients and healthy donors. A coculture system of K562 cells and several Cx43-modified bone marrow stromal cells (BMSCs) was established under IM treatment. Proliferation, cell cycle, apoptosis, and other indicators of K562 cells in different groups were detected to investigate the function and possible mechanism of Cx43. We assessed the Ca 2+ -related pathway by Western blotting. Tumor-bearing models were also established to validate the causal role of Cx43 in reversing IM resistance.
RESULTS:Low levels of Cx43 in BMs were observed in CML patients, and Cx43 expression was negatively correlated with HIF-1α. We also observed that K562 cells cocultured with BMSCs transfected with adenovirus-short hairpin RNA of Cx43 (BMSCs-shCx43) had a lower apoptosis rate and that their cell cycle was blocked in G0/G1 phase, while the result was the opposite in the Cx43-overexpression setting. Cx43 mediates gap junction intercellular communication (GJIC) through direct contact, and Ca 2+ is the key factor mediating the downstream apoptotic pathway. In animal experiments, mice bearing K562, and BMSCs-Cx43 had the smallest tumor volume and spleen, which was consistent with the in vitro experiments.
CONCLUSIONS:Cx43 deficiency exists in CML patients, promoting the generation of MRD and inducing drug resistance. Enhancing Cx43 expression and GJIC function in the HM may be a novel strategy to reverse drug resistance and promote IM efficacy.
